C-type natriuretic peptide inhibiting vascular calcification might involve decreasing bone morphogenic protein 2 and osteopontin levels

Molecular and Cellular Biochemistry

Volumn 392, Issue 1-2, 2014, Pages 65-76

  Chen, Jing Jing ^a,b   Zhang, Jing ^c   Cai, Yan ^d   Zhou, Ye Bo ^d   Wen, Ge Bo ^a   Tang, Chao Shu ^d   Qi, Yong Fen ^d   Jiang, Zhi Sheng ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

^b The Fifth People's Hospital of Jinan   (China)

^c BEIJING NORMAL UNIVERSITY   (China)

^d PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

C type natriuretic peptide; Vascular calcification; Vascular smooth muscle cells

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; ALKALINE PHOSPHATASE; ALPHA ACTIN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; COLECALCIFEROL; CYCLIC GMP; MESSENGER RNA; NATRIURETIC PEPTIDE RECEPTOR B; NATRIURETIC PEPTIDE TYPE C; NICOTINE; OSTEOPONTIN; BMP2 PROTEIN, RAT; PRIMER DNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; ENZYME ACTIVITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSMOTIC PUMP; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; UPREGULATION; VASCULAR SMOOTH MUSCLE; VASCULARIZATION; WESTERN BLOTTING; ANIMAL; BLOOD VESSEL; CALCINOSIS; DRUG EFFECTS; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BASE SEQUENCE; BLOOD VESSELS; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; DNA PRIMERS; MALE; NATRIURETIC PEPTIDE, C-TYPE; OSTEOPONTIN; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84905159306     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-014-2019-1     Document Type: Article

References (47)

1. Iribarren C, Sidney S, Sternfeld B (2000) Calcification of the aortic arch: risk factor and association with coronary heart disease, stroke, and peripheral vascular disease. JAMA 88:26-33
2. Huang Z, Li J, Jiang Z, Qi Y, Tang C, Du J (2003) Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol 42:89-97 (Pubitemid 36791355)
3. Cai DY, Yu F, Jiang W, Jiang HF, Pan CS, Qi YF, Chang L, Zhao J, Yang JH, Zhu MJ, Jia YX, Geng B, Ma TM, Pang YZ, Tang CS (2005) Adrenomedullin(27-52) inhibits vascular calcification in rats. Regul Pept 129:125-132 (Pubitemid 40775795)
4. Li GZ, Jiang W, Zhao J, Pan CS, Cao J, Tang CS, Chang L (2005) Ghrelin blunted vascular calcification in vivo and in vitro in rats. Regul Pept 129:167-176 (Pubitemid 40775800)
5. Jono S, Nishizawa Y, Shioi A, Morii H (1998) 1,25-Dihydroxy vitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98:1302-1306 (Pubitemid 28443394)
6. Essalihi R, Ouellette V, Hao Dao H, McKee MD, Moreau P (2004) Phenotypic modulation of vascular smooth muscle cells during medial arterial calcification: a role for endothelin? J Cardiovasc Pharmacol 44:S147-S150 (Pubitemid 40039666)
7. Jaffe IZ, Mendelsohn ME (2005) Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells. Circ Res 96:643-650 (Pubitemid 40478331)
8. Drake WM, Lowe SR, Mirtella A (2000) Desensitisation of calcitonin gene-related peptide responsiveness but not adrenomedullin responsiveness in vascular smooth muscle cells. J Endocrinol 165:133-138 (Pubitemid 30210573)
9. Hagiwara H, Inoue A, Yamaguchi A, Yokose S, Furuya M, Tanaka S, Hirose S (1996) cGMP produced in response to ANP and CNP regulates proliferation and differentiation of osteoblastic cells. Am J Physiol 270:C1311-C1318
10. Inoue A, Hayakawa T, Otsuka E, Kamiya A, Suzuki Y, Hirose S, Hagiwara H (1999) Correlation between induction of expression of biglycan and mineralization by C-type natriuretic peptide in osteoblastic cells. J Biochem 125:103-108 (Pubitemid 29085969)
11. Komatsu Y, Chusho H, Tamura N, Yasoda A, Miyazawa T, Suda M, Miura M, Ogawa Y, Nakao K (2002) Significance of C-type natriuretic peptide (CNP) in endochondral ossification: analysis of CNP knockout mice. J Bone Miner Metab 20:331-336 (Pubitemid 40645654)
12. Johnson RC, Leopold JA, Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99:1044-1059 (Pubitemid 44729928)
13. Shao JS, Cheng SL, Sadhu J, Towler DA (2010) Inflammation and the osteogenic regulation of vascular calcification: a review and perspective. Hypertension 55:579-592
14. Demer LL, Tintut Y (2008) Vascular calcification: pathobiology of a multifaceted disease. Circulation 117:2938-2948 (Pubitemid 351787058)
15. Peltonen TO, Taskinen P, Soini Y, Rysä J, Ronkainen J, Ohtonen P, Satta J, Juvonen T, Ruskoaho H, Leskinen H (2007) Distinct downregulation of C-type natriuretic peptide system in human aortic valve stenosis. Circulation 116:1283-1289 (Pubitemid 47517540)
16. Cai Y, Teng X, Pan CS, Duan XH, Tang CS, Qi YF (2010) Adrenomedullin up-regulates osteopontin and attenuates vascular calcification via the cAMP/PKA signaling pathway. Acta Pharmacol Sin 31:1359-1366
17. Cai Y, Xu MJ, Teng X, Zhou YB, Chen L, Zhu Y, Wang X, Tang CS, Qi YF (2010) Intermedin inhibits vascular calcification by increasing the level of matrix γ-carboxyglutamic acid protein. Cardiovasc Res 85:864-873
18. Zhou YB, Jin SJ, Cai Y, Teng X, Chen L, Tang CS, Qi YF (2009) Lanthanum acetate inhibits vascular calcification induced by vitamin D3 plus nicotine in rats. Exp Biol Med 234:908-917
19. Shioi A, Nishizawa Y, Jono S, Koyama H, Hosoi M, Morii H (1995) Beta glycerophosphate accelerates calcification in cultured bovine vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 15:2003-2009
20. Schurgers LJ, Spronk HM, Skepper JN, Hackeng TM, Shanahan CM, Vermeer C, Weissberg PL, Proudfoot D (2007) Post-translational modifications regulate matrix Gla protein function: importance for inhibition of vascular smooth muscle cell calcification. J Thromb Haemost 5:2503-2511 (Pubitemid 350154362)
21. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R, Schinke T, Karsenty G, Giachelli CM (2001) Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbf α 1 and downregulation of smooth muscle lineage markers. Circ Res 89:1147-1154 (Pubitemid 34627872)
22. London GM, Marchais SJ, Guerin AP, Metivier F (2005) Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 14:525-531 (Pubitemid 41531842)
23. Parifitt AM (1969) Soft-tissue calcification in uremia. Arch Intern Med 124:544-556
24. Niederhoffer N, Bobyshev YV, Lartaud-Idjouadien I, Giummelly P, Atkinson J (1997) Aortic calcification produced by vitamin D3 plus nicotine. J Vasc Res 34:386-398 (Pubitemid 27414508)
25. Pan CS, Qi YF, Wu SY, Jiang W, Li GZ, Tang CS (2004) The role of adrenomedullin and its receptor system in cardiovascular calcification of rat induced by Vitamin D(3) plus nicotine. Peptides 25:601-608 (Pubitemid 38681059)
26. Potter LR (2011) Natriuretic peptide metabolism, clearance and degradation. FEBS J 278:1808-1817
27. Doherty MJ, Ashton BA, Walsh S, Beresford JN, Grant ME, Canfield AE (1998) Vascular pericytes express osteogenic potential in vitro and in vivo. J Bone Miner Res 13:828-838 (Pubitemid 28224199)
28. D'Amelio P, Isaia G, Isaia GC (2009) The osteoprotegerin/RANK/RANKL system: a bone key to vascular disease. J Endocrinol Invest 32:6-9
29. Hagiwara H, Sakaguchi H, Itakura M, Yoshimoto T, Furuya M, Tanaka S, Hirose S (1994) Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B. J Biol Chem 269:10729-10733 (Pubitemid 24198280)
30. Suda M, Tanaka K, Fukushima M, Natsui K, Yasoda A, Komatsu Y, Ogawa Y, Itoh H, Nakao K (1996) C-type natriuretic peptide as an autocrine/paracrine regulator of osteoblast. Biochem Biophys Res Commun 223:1-6
31. Inoue A, Kobayashi Y, Ishizuka M, Hirose S, Hagiwara H (2002) Identification of a novel osteoblastic gene, inducible by C-type natriuretic peptide, whose transcript might function in mineralization as a noncoding RNA. Calcif Tissue Int 70:111-116 (Pubitemid 36935459)
32. Inoue A, Hiruma Y, Hirose S, Yamaguchi A, Furuya M, Tanaka S, Hagiwara H (1996) Stimulation by C-type natriuretic peptide of the differentiation of clonal osteoblastic MC3T3-E1 cells. Biochem Biophys Res Commun 221:703-707 (Pubitemid 26153927)
33. Yasoda A, Kitamura H, Fujii T, Kondo E, Murao N, Miura M, Kanamoto N, Komatsu Y, Arai H, Nakao K (2009) Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology 150:3138-3144
34. Yasoda A, Nakao K (2010) Translational research of C-type natriuretic peptide (CNP) into skeletal dysplasias. Endocr J 57:659-666
35. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX (2003) Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 63:1003-1011 (Pubitemid 36315578)
36. Cola C, Almeida M, Li D, Romeo F, Mehta JL (2004) Regulatory role of endothelium in the expression of genes affecting arterial calcification. Biochem Biophys Res Commun 320:424-427 (Pubitemid 38798884)
37. Engelse MA, Neele JM, Bronckers AL, Pannekoek H, de Vries CJ (2001) Vascular calcification: expression patterns of the osteoblast-specific gene core binding factor alpha-1 and the protective factor matrix gla protein in human atherogenesis. Cardiovasc Res 52:281-289 (Pubitemid 33000405)
38. Mohler ER, Adam LP, McClelland P, Graham L, Hathaway DR (1997) Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 17:547-552 (Pubitemid 27133146)
39. Chen B, Lin H, Wang J, Zhao Y, Wang B, Zhao W, Sun W, Dai J (2007) Homogeneous osteogenesis and bone regeneration by demineralized bone matrix loading with collagen-targeting bone morphogenetic protein-2. Biomaterials 28:1027-1035 (Pubitemid 44816374)
40. Liu F, Zhong H, Liang JY, Fu P, Luo ZJ, Zhou L, Gou R, Huang J (2010) Effect of high glucose levels on the calcification of vascular smooth muscle cells by inducing osteoblastic differentiation and intracellular calcium deposition via BMP-2/Cbfα-1 pathway. J Zhejiang Univ Sci B 11:905-911
41. Wallin R, Cain D, Hutson SM, Sane DC, Loeser R (2000) Modulation of the binding of matrix Gla protein (MGP) to bone morphogenetic protein-2 (BMP-2). Thromb Haemost 84:1039-1044 (Pubitemid 32014040)
42. Scotland RS, Ahluwalia A, Hobbs AJ (2005) C-type natriuretic peptide in vascular physiology and disease. Pharmacol Ther 105:85-93
43. Chrysant SG (2013) Effectiveness and safety of phosphodiesterase 5 inhibitors in patients with cardiovascular disease and hypertension. Curr Hypertens Rep 15:475-483
44. Kuhn M (2012) Endothelial actions of atrial and B-type natriuretic peptides. Br J Pharmacol 166:522-531
45. Yamaguchi A, Katagiri T, Ikeda T, Wozney JM, Rosen V, Wang EA, Kahn AJ, Suda T, Yoshiki S (1991) Recombinant human bone morphogenetic protein-2 stimulates osteoblastic maturation and inhibits myogenic differentiation in vitro. J Cell Biol 113:681-687 (Pubitemid 21926024)
46. Yamaguchi A, Kahn AJ (1991) Clonal osteogenic cell lines express myogenic and adipocytic developmental potential. Calcif Tissue Int 49:221-225
47. 2+ efflux. PNAS 84:5685-5689